Key Points
- COO Jon Foster sold 21,713 HCA shares for about $10.75 million at an average price of $494.95, reducing his stake by 68.47% to 10,000 shares.
- HCA reported quarterly earnings of $7.22 per share, beating the $6.65 consensus, and revenue of $19.85 billion, above estimates and up 3.6% year over year.
- Analysts maintain a “Moderate Buy” consensus, with a $480.13 average price target; HCA also announced a quarterly dividend of $0.78 per share.
HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) EVP Michael Schlosser sold 1,200 shares of the business's stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the sale, the executive vice president owned 1,443 shares in the company, valued at $713,779.95. This represents a 45.40% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
HCA Healthcare Price Performance
Shares of HCA stock opened at $494.44 on Friday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The company has a market cap of $103.28 billion, a price-to-earnings ratio of 16.38, a price-to-earnings-growth ratio of 1.56 and a beta of 1.11. The stock's fifty day moving average price is $443.66 and its 200 day moving average price is $445.25.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, beating the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The firm had revenue of $19.85 billion during the quarter, compared to analysts' expectations of $19.33 billion. During the same quarter last year, the firm earned $6.96 earnings per share. The business's revenue for the quarter was up 3.6% on a year-over-year basis. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.
HCA Healthcare Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare's payout ratio is presently 10.34%.
Analyst Ratings Changes
Several equities analysts recently commented on HCA shares. KeyCorp increased their price objective on shares of HCA Healthcare from $435.00 to $490.00 and gave the company an "overweight" rating in a research note on Wednesday, October 28th. Weiss Ratings raised HCA Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, October 8th. TD Cowen boosted their price target on HCA Healthcare from $460.00 to $486.00 and gave the stock a "buy" rating in a research report on Wednesday, October 28th. Royal Bank Of Canada upped their target price on shares of HCA Healthcare from $496.00 to $521.00 and gave the company an "outperform" rating in a report on Friday, October 30th. Finally, Oppenheimer lowered their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating for the company in a report on Monday, July 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $480.13.
Get Our Latest Analysis on HCA Healthcare
HCA Healthcare News Summary
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
- Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
- Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
- Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
- Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
- Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
- Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Condor Capital Management boosted its position in HCA Healthcare by 1.8% during the 3rd quarter. Condor Capital Management now owns 10,926 shares of the company's stock worth $4,663,000 after acquiring an additional 192 shares during the period. Wellington Grp LLC boosted its holdings in HCA Healthcare by 51.4% in the 3rd quarter. Wellington Grp LLC now owns 3,303 shares of the company's stock valued at $1,410,000 after purchasing an additional 1,122 shares during the period. BCV Asset Management Inc. increased its stake in shares of HCA Healthcare by 2.6% in the third quarter. BCV Asset Management Inc. now owns 74,598 shares of the company's stock valued at $31,963,000 after buying an additional 1,904 shares during the period. ProVise Management Group LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $255,000. Finally, Money Concepts Capital Corp grew its position in HCA Healthcare by 6.7% in the third quarter. Money Concepts Capital Corp now owns 719 shares of the company's stock worth $307,000 after acquiring an additional 45 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.
HCA Healthcare Company Profile
(
Get Free Report)
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.
The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.
Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
